Community Research and Development Information Service - CORDIS

Results 1 - 10 of 479
Order by: Results/page:
12 3 4 5 6 7 8 9 10 > >| 
Taking imaging into the therapeutic domain: Self-regulation of brain systems for mental disorders
ID: 602186
Start date: 2013-11-01, End date: 2018-10-31
Our proposal is based on the idea that real-time functional neuroimaging can be used to train patients to regulate their own brain activity via neurofeedback training and thus modulate the brain networks of mental disorder, restore function, improve symptoms and promote resil...
Programme: FP7-HEALTH
Record Number: 109338
Last updated on: 2017-12-11
Translation of the direct-on-blood PCR-NALFIA system into an innovative near point-of-care diagnostic for malaria
ID: 601714
Start date: 2013-09-01, End date: 2017-02-28
Accurate diagnosis of malaria is essential to timely install proper treatment. Current diagnostic methods for malaria have limitations, such as detection limit and problems with antigen persistence after successful treatment (rapid diagnostic tests) or may require technical e...
Programme: FP7-HEALTH
Record Number: 108624
Last updated on: 2017-12-11
Better Experimental Screening and Treatment for Primary Ciliary Dyskinesia
ID: 305404
Start date: 2012-12-01, End date: 2016-05-31
Primary Ciliary Dyskinesia (PCD) is a rare genetically heterogeneous disorder which results from dysfunction of motile hair-like organelles (cilia) that results in severe, chronic airways disease. Due to other cilia-related disease mechanisms several other organ systems like ...
Programme: FP7-HEALTH
Record Number: 106177
Last updated on: 2017-12-11
Bringing Regenerative Medicine into the market: Allogeneic eASCs Phase IB/IIA clinical trial for treating Rheumatoid Arthritis
ID: 279174
Start date: 2012-01-01, End date: 2014-12-31
Treating Rheumatoid Arthritis (RA) is a crucial challenge for the health systems. RA is the most common inflammatory arthritis, affecting 0.5% to 1% of the general population worldwide with little variation of the prevalence among countries. The current pharmacological manage...
Programme: FP7-HEALTH
Record Number: 102108
Last updated on: 2017-12-11
A novel generation of skin substitutes to clinically treat a broad spectrum of severe skin defects
ID: 279024
Start date: 2011-10-01, End date: 2016-09-30
Large full-thickness skin defects resulting from burns, soft tissue trauma, congenital giant nevi, tumour resection, and disease leading to skin necrosis, represent a significant and common clinical problem worldwide. This problem is far from being solved. The main challenge ...
Programme: FP7-HEALTH
Record Number: 101996
Last updated on: 2017-12-11
Rapid, robust & scaleable platform technology for fully automated reference laboratory grade Polymerase Chain Reaction (PCR) based diagnostics regardless of global setting
ID: 201569
Start date: 2008-07-01, End date: 2011-06-30
RANGER addresses the HEALTH-2007-2.3.3-4: Innovative point-of-care (POC) diagnostic tests for influenza call by providing a innovative solution to the immediate need for a rapid, robust, cost effective & user friendly POC diagnostic for influenza. We will develop the followin...
Programme: FP7-HEALTH
Record Number: 88189
Last updated on: 2017-12-11
Benchmarking Integrated Care for better Management of Chronic and Age-related Conditions in Europe
ID: 305821
Start date: 2012-09-01, End date: 2016-08-31
INTEGRATE aims at gaining valuable insights into integrated care, starting from the premise that it offers benefits for patients and for Europe’s health and social security systems, which are facing the challenges of an ageing population and increased chronic conditions. For ...
Programme: FP7-HEALTH
Record Number: 105315
Last updated on: 2017-12-07
Observational Prolonged Trial In Myotonic dystrophy type 1 to Improve QoL-Standards, a Target Identification Collaboration
ID: 305697
Start date: 2012-11-01, End date: 2017-04-30
OPTIMISTIC is a proposal for a European collaborative project of doctors, scientists, relevant stakeholders (TREAT-NMD, patient organizations) and SMEs with the aim to improve clinical practice for patients suffering from a rare, inherited, and neglected disease, myotonic dys...
Programme: FP7-HEALTH
Record Number: 106243
Last updated on: 2017-12-07
Beta cell preservation via antigen-specific immunotherapy in Type 1 Diabetes: Enhanced Epidermal Antigen Delivery Systems
ID: 305305
Start date: 2012-09-01, End date: 2017-05-31
Current approaches to improving glycaemic control in type 1 diabetes are centered on increasingly complex insulin delivery systems. However, less than 30% of patients can achieve target levels of glucose control with this approach even in a clinical trial setting and many pat...
Programme: FP7-HEALTH
Record Number: 105252
Last updated on: 2017-12-07
Monitoring innate immunity in arthritis and mucosal inflammation
ID: 305266
Start date: 2013-02-01, End date: 2016-04-30
In chronic joint disease, only a subgroup of patients has classical autoantibodies, while the other variants are seronegative arthritis syndromes with a predominance of innate immune disturbances. These forms of joint diseases frequently show extra-articular manifestations of...
Programme: FP7-HEALTH
Record Number: 106695
Last updated on: 2017-12-07
12 3 4 5 6 7 8 9 10 > >| 
List retrieved on: 2017-12-14
Follow us on: RSS Facebook Twitter YouTube Managed by the EU Publications Office Top